Stoke Therapeutics Appoints Eric Olson, MS, MBA as Chief Business Officer

Go back to Stoke Therapeutics Appoints Eric Olson, MS, MBA as Chief Business Officer
(NASDAQ: STOK) Delayed: 32.29 +0.89 (2.83%)
Previous Close $31.40    52 Week High
Open $31.76    52 Week Low
Day High $32.77    P/E N/A 
Day Low $31.52    EPS
Volume 1,274,423